In a retrospective study, patients receiving direct oral anticoagulants had similar rates of intracranial hemorrhage compared with recipients of low-molecular-weight heparin.
Starting treatment within 4 days rather than later leads to fewer early recurrent strokes with no significant intracranial hemorrhage signal, according to a comprehensive meta-analysis.